Study Stopped
Impact of Covid-19 and staffing has required us to suspend this study
The Role of Unsteady Wall Shears Stress Stimuli on Human Umbilical Vein Endothelial Cells Harvested From Umbilical Cords
HUVEC
1 other identifier
observational
13
1 country
1
Brief Summary
The aim of this study is to obtain and test endothelial cells (EC's) from umbilical cords to examine specific properties of these cells which make up the inner lining of blood vessels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2019
CompletedStudy Start
First participant enrolled
November 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2024
CompletedApril 12, 2024
April 1, 2024
3.3 years
October 9, 2019
April 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The identification of Endothelial Cell phenotype
To identify this phenotype by assessing the endothelial identity markers, the endothelial to mesenchymal transition markers and the regulation of genes involved in EC quiescence.
2 years
Eligibility Criteria
Women attending Maternity Services in Limerick who are pregnant and due for routine delivery that meet all the inclusion and exclusion criteria.
You may qualify if:
- Patients who are attending the Maternity Services who are pregnant and due for routine delivery.
- Aged 18- 40 years.
- Are willing and capable to voluntarily sign a statement of informed consent to take part in this investigation.
- Patients due to give birth to twins will be included in this study. Women having both "normal" delivery and caesarean section delivery will be included in this study.
You may not qualify if:
- Patients unable to provide informed consent.
- Patients who are under the age of 18 and over the age of 40 years.
- Patients who are deemed unsuitable due to any circumstances as deemed appropriate by the Consultant.
- Patients with a Blood Borne Virus (HIV Type 1, HIV Type 2, Hepatitis B, Hepatitis C) will be excluded from the study.
- Patients with diabetes that is not gestational in nature will be excluded from this study.
- Patients due to deliver triplets or more will be excluded from this study.
- Patients who deliver their baby before 37 weeks gestation will not have umbilical cord tissue retained for study purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital of Limericklead
- University of Limerickcollaborator
Study Sites (1)
University Hospital Limerick
Limerick, Ireland
Biospecimen
Endothelial cells will be retrieved from the endothelial vein of human umbilical cord tissue that would be otherwise discarded.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eamon Kavanagh, MD FRCSI
University Hospital of Limerick
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Eamon Kavanagh Prinicipal Investigator
Study Record Dates
First Submitted
October 9, 2019
First Posted
October 10, 2019
Study Start
November 20, 2019
Primary Completion
March 22, 2023
Study Completion
March 22, 2024
Last Updated
April 12, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share